These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 9517963

  • 1. Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium.
    Rybak MJ, Cappelletty DM, Moldovan T, Aeschlimann JR, Kaatz GW.
    Antimicrob Agents Chemother; 1998 Mar; 42(3):721-4. PubMed ID: 9517963
    [Abstract] [Full Text] [Related]

  • 2. Comparative activity of linezolid against staphylococci and enterococci isolated in Italy.
    Stefani S, Mezzatesta ML, Tempera G, Debbra E, Schito AM, Nicoletti G, Marchére A.
    Clin Microbiol Infect; 2002 Jun; 8(6):368-72. PubMed ID: 12084106
    [Abstract] [Full Text] [Related]

  • 3. Activities of the oxazolidinones linezolid and eperezolid in experimental intra-abdominal abscess due to Enterococcus faecalis or vancomycin-resistant Enterococcus faecium.
    Schülin T, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM.
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2873-6. PubMed ID: 10582874
    [Abstract] [Full Text] [Related]

  • 4. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium.
    Jevitt LA, Smith AJ, Williams PP, Raney PM, McGowan JE, Tenover FC.
    Microb Drug Resist; 2003 Dec; 9(4):389-93. PubMed ID: 15000746
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE, Smith JR, Raut A, Rybak MJ.
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of the oxazolidinone RWJ-416457 against linezolid-resistant and -susceptible staphylococci and enterococci.
    Livermore DM, Warner M, Mushtaq S, North S, Woodford N.
    Antimicrob Agents Chemother; 2007 Mar; 51(3):1112-4. PubMed ID: 17210773
    [Abstract] [Full Text] [Related]

  • 7. Novel tetrahydro-thieno pyridyl oxazolidinone: an antibacterial agent.
    Lohray BB, Lohray VB, Srivastava BK, Kapadnis PB, Pandya P.
    Bioorg Med Chem; 2004 Sep 01; 12(17):4557-64. PubMed ID: 15358283
    [Abstract] [Full Text] [Related]

  • 8. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L, Nicola L, De Vecchi E.
    Clin Microbiol Infect; 2008 Jun 01; 14(6):608-11. PubMed ID: 18397336
    [Abstract] [Full Text] [Related]

  • 9. In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.
    Sweeney MT, Zurenko GE.
    Antimicrob Agents Chemother; 2003 Jun 01; 47(6):1902-6. PubMed ID: 12760865
    [Abstract] [Full Text] [Related]

  • 10. Post-antibiotic growth suppression of linezolid against Gram-positive bacteria.
    Munckhof WJ, Giles C, Turnidge JD.
    J Antimicrob Chemother; 2001 Jun 01; 47(6):879-83. PubMed ID: 11389123
    [Abstract] [Full Text] [Related]

  • 11. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents.
    Zurenko GE, Yagi BH, Schaadt RD, Allison JW, Kilburn JO, Glickman SE, Hutchinson DK, Barbachyn MR, Brickner SJ.
    Antimicrob Agents Chemother; 1996 Apr 01; 40(4):839-45. PubMed ID: 8849237
    [Abstract] [Full Text] [Related]

  • 12. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium.
    Allen GP, Bierman BC.
    Int J Antimicrob Agents; 2009 Jul 01; 34(1):21-4. PubMed ID: 19243921
    [Abstract] [Full Text] [Related]

  • 13. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.
    Kaatz GW, Seo SM.
    Antimicrob Agents Chemother; 1996 Mar 01; 40(3):799-801. PubMed ID: 8851617
    [Abstract] [Full Text] [Related]

  • 14. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN, Fritsche TR, Sader HS, Ross JE.
    Diagn Microbiol Infect Dis; 2007 Nov 01; 59(3):309-17. PubMed ID: 17720350
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium.
    Metallidis S, Chatzidimitriou M, Nikolaidis P, Tsona A, Bisiklis A, Kollaras P, Tsiakiri E, Koumentaki E, Alexiou-Daniel S.
    J Chemother; 2003 Oct 01; 15(5):442-8. PubMed ID: 14603881
    [Abstract] [Full Text] [Related]

  • 16. Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid.
    Schaadt RD, Batts DH, Daley-Yates PT, Pawsey SD, Stalker DJ, Zurenko GE.
    Diagn Microbiol Infect Dis; 1997 Aug 01; 28(4):201-4. PubMed ID: 9327249
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.
    Patel R, Rouse MS, Piper KE, Steckelberg JM.
    Diagn Microbiol Infect Dis; 1999 Jun 01; 34(2):119-22. PubMed ID: 10354862
    [Abstract] [Full Text] [Related]

  • 18. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
    Brauers J, Kresken M, Menke A, Orland A, Weiher H, Morrissey I.
    Int J Antimicrob Agents; 2007 Mar 01; 29(3):322-5. PubMed ID: 17204403
    [Abstract] [Full Text] [Related]

  • 19. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH, Huang YT, Liao CH, Sheng WH, Hsueh PR.
    Antimicrob Agents Chemother; 2015 Oct 01; 59(10):6262-5. PubMed ID: 26248355
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
    Johnson AP, Warner M, Livermore DM.
    J Antimicrob Chemother; 2002 Jul 01; 50(1):89-93. PubMed ID: 12096011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.